CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,206 | 35,275 | ||
| 2023-02-14 | Wolff Stefani EVP and COO | Grant or award · Employee Stock Option (right to buy) | +88,900 | 88,900 | ||
| 2023-02-14 | Wolff Stefani EVP and COO | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2023-02-14 | van Houte Hans Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +88,900 | 88,900 | ||
| 2023-02-14 | van Houte Hans Chief Financial Officer | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2023-02-14 | SANDS ARTHUR T President, CEO | Grant or award · Employee Stock Option (right to buy) | +448,000 | 448,000 | ||
| 2023-02-14 | Ring Christine General Counsel | Grant or award · Employee Stock Option (right to buy) | +88,900 | 88,900 | ||
| 2023-02-14 | Ring Christine General Counsel | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2023-02-14 | Hansen Gwenn Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +88,900 | 88,900 | ||
| 2023-02-14 | Hansen Gwenn Chief Scientific Officer | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2023-01-30 | Wolff Stefani EVP and COO | Option exercise | +962 | 4,364 | ||
| 2023-01-30 | Wolff Stefani EVP and COO | Sale | −424 | $11.78 | $5K | 3,940 |
| 2023-01-30 | Wolff Stefani EVP and COO | Option exercise · Restricted Stock Units | −962 | 11,544 | ||
| 2023-01-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,886 | 77,689 | ||
| 2023-01-30 | van Houte Hans Chief Financial Officer | Sale | −924 | $11.78 | $11K | 76,765 |
| 2023-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,886 | 34,633 | ||
| 2023-01-30 | Ring Christine General Counsel | Option exercise | +1,924 | 8,109 | ||
| 2023-01-30 | Ring Christine General Counsel | Sale | −848 | $11.78 | $10K | 7,261 |
| 2023-01-30 | Ring Christine General Counsel | Option exercise · Restricted Stock Units | −1,924 | 23,089 | ||
| 2023-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,207 | 24,421 |
Page 26 of 32 · 632 trades